CORRECT: Tissue Regenix Hires NuPak Medical Founder As New CFO

Fri, 22nd Jan 2021 11:19

(Correcting name and headquarters location of Aperion Biologics.)

Tissue Regenix Group PLC - Leeds-based medical devices for regenerative medicine - Hires David Cocke as chief financial officer and board director. Cocke founded NuPak Medical Ltd, a contract manufacturer of sterile disposable medical devices, back in 1997. NuPak was acquired by Katena Products Inc in 2017. Cocke also was CFO of San Antonio, Texas-based Aperion Biologics Inc. He starts at Tissue Regenix immediately.

Current stock price: 0.51 pence

Year-to-date change: down 5.6%

By Tom Waite; thomaslwaite@alliancenews.com

Related Shares

More News

18 Apr 2024 14:12

UK shareholder meetings calendar - next 7 days

19 Mar 2024 14:24

Tissue Regenix annual loss narrows sharply as revenue jumps

(Alliance News) - Tissue Regenix Group PLC on Tuesday said it was aiming for longer-term growth as it reported a sharp reduction in its annual losses.

12 Mar 2024 14:29

UK earnings, trading statements calendar - next 7 days

6 Feb 2024 10:42

IN BRIEF: Tissue Regenix ships first allograft products order

Tissue Regenix Group PLC - Leeds, England-based medical devices - First order of its allograft products has been shipped from its third-party Irish lo...

25 Jan 2024 20:21

TRADING UPDATES: Treatt revenue falls; Secure Trust profit picks up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: